NCT06766773Active, not recruiting
Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer
Warming With a Composite Warming Strategy Reduces Intraoperative Hypothermia in Patients Undergoing Open Hepatectomy for Liver Cancer: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 10 Jan 2025
Brief summary (registry, in English)
The composite warming strategy has a certain effect on preventing hypothermia during cancer liver resection surgery. This study aims to explore the application of compound warming strategy in perioperative nursing of cancer liver resection. This study will compare two groups: the control group using perioperative forced warming measures, and the experimental group using a composite warming strategy. Main objective: Intraoperative temperature changes Secondary objective: incidence of complications The investigators' investigated the practicality and effectiveness of a combined warming strategy in open liver resection surgery. In addition, the investigators also conducted a quantitative correlation study on the incidence of hypothermia during the surgical process. This provides evidence-based guidance for the prevention of hypothermia during surgery.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 4 Jan 2025
- Start date
- 1 Jan 2020
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- The First People's Hospital of Neijiang
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06766773
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 1 Jan 2020 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of medications/substances impacting thermoregulation (e.g., illicit drugs, alcohol abuse, antipyretics).
Other illness
- Metastatic liver disease or emergency liver surgery required.
- Contraindications to warming devices (e.g., certain skin conditions or advanced peripheral vascular disease).
- Cognitive impairment or psychiatric disorders affecting study understanding or informed consent.
- History of malignancies other than liver cancer affecting survival or perioperative risk.
- Recent history (within six months) of myocardial infarction or cerebrovascular accident.
- Uncontrolled diabetes mellitus or other significant endocrine disorders.
Lab values
- Severe anemia (hemoglobin below a predetermined threshold).
Age
- Aged under 18 or over 75 years.
Other
- Chronic analgesic use that could interfere with pain assessment.
- Participation in another clinical trial within the past 30 days.
- Pregnant or lactating.
- Presence of an implantable device (e.g., pacemakers or defibrillators) that could be affected by warming strategies.
Who the study is looking for
- Aged between 18 and 75 years.
- Scheduled for elective open hepatectomy to treat hepatocellular carcinoma, confirmed by preoperative biopsy or imaging.
- Adequate liver function (Child-Pugh score A or B).
- American Society of Anesthesiologists (ASA) physical status classification of I, II, or well-controlled III.
- Informed consent provided for participation.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First People's Hospital of Neijiang Coordinator of this site? Confirm its status | Neijiang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.